Alex A. Adjei, MD, PhD
Roswell Park Cancer Institute
5
1
5
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+5 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (5)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Jeffrey A. Bogart, MD
State University of New York - Upstate Medical University
Shared therapeutic areas:
Worked with same sponsors:
Hak Choy, MD
Simmons Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Mark Dobelbower, MD PhD
University of Alabama Medical Center
Shared therapeutic areas:
Worked with same sponsors:
Gregory A. Masters, MD
CCOP - Christiana Care Health Services
Shared therapeutic areas:
Worked with same sponsors:
Steven E. Schild, MD
Mayo Clinic
Shared therapeutic areas:
Worked with same sponsors:
Tien Hoang, MD
University of Wisconsin, Madison
Shared therapeutic areas:
Worked with same sponsors:
Jeff Sloan, PhD, HSR
Mayo Clinic
Shared therapeutic areas:
Worked with same sponsors:
Ken Forster, PhD
H. Lee Moffitt Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
George Blumenschein, MD
M.D. Anderson Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Joe Y. Chang, MD PhD
M.D. Anderson Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (5)
Showing 5 of 5 trials
Pemetrexed Disodium and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
KX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to Treatment
All 5 trials loaded